Leap Therapeutics Inc (LPTX)
0.3999
+0.01
(+2.54%)
USD |
NASDAQ |
Mar 25, 16:00
0.3999
0.00 (0.00%)
After-Hours: 16:52
Leap Therapeutics Max Drawdown (5Y): 98.84% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Inovio Pharmaceuticals Inc | 99.53% |
| CervoMed Inc | 99.94% |
| AIM ImmunoTech Inc | 98.88% |
| Protalix BioTherapeutics Inc | 94.38% |
| Armata Pharmaceuticals Inc | 99.88% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -62.15 |
| Beta (5Y) | 0.3475 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 113.8% |
| Historical Sharpe Ratio (5Y) | -0.5023 |
| Historical Sortino (5Y) | -1.010 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.67% |